The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study

Khalaf Kridin; Noor Mruwat; Diamant Thaci; Ralf J. Ludwig

doi:10.1111/jdv.18830

The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study

Khalaf Kridin, Noor Mruwat, Diamant Thaci, Ralf J. Ludwig

Bar-Ilan University - Azrieli Faculty of Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	e683-e685
Journal	Journal of the European Academy of Dermatology and Venereology
Volume	37
Issue number	5
DOIs	https://doi.org/10.1111/jdv.18830
State	Published - May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jdv.18830

Cite this

@article{dd95a69d06e34477b1f08d2d25c9ab8e,

title = "The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study",

author = "Khalaf Kridin and Noor Mruwat and Diamant Thaci and Ludwig, {Ralf J.}",

year = "2023",

month = may,

doi = "10.1111/jdv.18830",

language = "אנגלית",

volume = "37",

pages = "e683--e685",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis

T2 - A large-scale global cohort study

AU - Kridin, Khalaf

AU - Mruwat, Noor

AU - Thaci, Diamant

AU - Ludwig, Ralf J.

PY - 2023/5

Y1 - 2023/5

UR - http://www.scopus.com/inward/record.url?scp=85146085538&partnerID=8YFLogxK

U2 - 10.1111/jdv.18830

DO - 10.1111/jdv.18830

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 36545934

AN - SCOPUS:85146085538

SN - 0926-9959

VL - 37

SP - e683-e685

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 5

ER -

The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large-scale global cohort study

UN SDGs

Access to Document

Other files and links

Cite this